Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

ENOV vs MSA: stock comparison and AI forecast

Enovis Corp (ENOV) and Msa Safety Inc (MSA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

ENOV Enovis Corp

Market Cap
$1.65B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

MSA Msa Safety Inc

Price
$169.99 -1.1% · 6M
Market Cap
$6.56B
P/E Ratio
21.8x
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

ENOV · MSA

Key facts

  • MSA is 4.0 times larger than ENOV by market capitalization ($6.56B against $1.65B).
  • MSA turns 15.0% of its revenue into net income, against -22.9% for ENOV.
  • ENOV carries 1.50 times debt per unit of equity, against 1.29 times for MSA.
  • MSA yields 1.26% in dividends; ENOV pays none.
  • Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricENOVMSA
Market Cap$1.65B$6.56B
P/E Ratio–21.82x
P/B Ratio1.11x4.57x
Dividend Yield–1.26%
EPS$-10.06$7.79
Book Value/Share$25.89$37.17
Revenue/Share$39.99$52.21
FCF/Share$1.21$8.35

Profitability & Margins

MetricENOVMSA
ROE-35.3%21.1%
ROA-14.1%9.2%
ROIC-15.1%14.0%
Gross Margin61.3%47.3%
Operating Margin-20.6%20.2%
Net Margin-22.9%15.0%
EBT Margin-21.8%19.8%
Tax Rate-5.0%24.2%

Financial Health

MetricENOVMSA
Current Ratio2.15x2.65x
Quick Ratio1.08x1.66x
D/E Ratio1.50x1.29x
Financial Leverage2.50x2.29x
Interest Coverage0.4x3.5x
Working Capital$668M$617M

Cash Flow

MetricENOVMSA
Operating Cash Flow$259M$376M
Free Cash Flow$70M$322M
Capital Spending-$189M-$54M
OCF Growth YoY19.3%7.5%
FCF Growth YoY205.6%13.8%
FCF/Sales3.0%16.0%
CapEx/Sales8.2%2.7%

Operational Efficiency

MetricENOVMSA
Asset Turnover0.62x0.61x
Receivables Turnover5.4x5.4x
Inventory Turnover1.4x2.9x
Fixed Assets Turnover4.4x7.1x
Days Sales Outstanding68 days68 days
Days Inventory254 days127 days
Payables Period82 days50 days
Cash Conversion Cycle239 days145 days

Income Statement

MetricENOVMSA
Total Revenue$2.31B$2.01B
Operating Income-$475M$407M
Net Income-$527M$303M
R&D Expense$126M$72M
SG&A Expense$1.08B$459M
Cost of Goods Sold$892M$1.06B

Dividend & Shareholder Information

MetricENOVMSA
Dividends Per Share–$2.15
Payout Ratio–27.6%
Shares Outstanding58M39M
Net Income Growth–8.2%
EPS Growth–9.9%
FAQ

ENOV vs MSA: stock comparison and AI forecast

Which is bigger, ENOV or MSA?

MSA is 4.0 times larger than ENOV by market capitalization ($6.56B against $1.65B).

Which one does Intratio's AI model rank higher, ENOV or MSA?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.